Hilltop Holdings Inc. bought a new stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The firm bought 15,117 shares of the electronics maker’s stock, valued at approximately $908,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Modern Wealth Management LLC acquired a new stake in shares of Dolby Laboratories in the 1st quarter valued at about $288,000. Arrowstreet Capital Limited Partnership lifted its stake in Dolby Laboratories by 507.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 124,509 shares of the electronics maker’s stock valued at $7,478,000 after buying an additional 104,014 shares during the last quarter. Sei Investments Co. lifted its position in Dolby Laboratories by 26.4% in the 1st quarter. Sei Investments Co. now owns 308,307 shares of the electronics maker’s stock valued at $18,516,000 after purchasing an additional 64,306 shares during the last quarter. Cetera Investment Advisers raised its holdings in shares of Dolby Laboratories by 50.1% during the first quarter. Cetera Investment Advisers now owns 8,681 shares of the electronics maker’s stock valued at $521,000 after buying an additional 2,898 shares during the last quarter. Finally, First Trust Advisors LP boosted its position in Dolby Laboratories by 19.9% during the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after acquiring an additional 374,405 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Insider Buying and Selling at Dolby Laboratories
In other news, CFO Robert J. Park sold 4,895 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the transaction, the chief financial officer owned 81,490 shares in the company, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CMO Todd Pendleton sold 11,876 shares of Dolby Laboratories stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total transaction of $647,835.80. Following the completion of the sale, the chief marketing officer directly owned 41,480 shares of the company’s stock, valued at approximately $2,262,734. The trade was a 22.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 47,458 shares of company stock valued at $2,639,537 over the last three months. 37.93% of the stock is owned by insiders.
Dolby Laboratories Stock Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the previous year, the company posted $1.34 earnings per share. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts predict that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.9%. Dolby Laboratories’s payout ratio is 56.92%.
Analysts Set New Price Targets
Several analysts have recently weighed in on the company. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Thursday, June 11th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.75.
Read Our Latest Stock Report on DLB
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
See Also
- Five stocks we like better than Dolby Laboratories
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
